We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAYS:NASDAQJ. W. Mays, Inc. Analysis

Data as of 2026-04-16 - not real-time

$40.49

Latest Price

8/10Risk

Risk Level: High

Executive Summary

J.W. Mays, Inc. (MAYS) is trading at $40.49, which sits just above its 20‑day SMA of $40.90 and well above the 200‑day SMA of $39.63, indicating a neutral price bias. Technical signals are mixed: the RSI at 40.3 suggests neither overbought nor oversold conditions, while the MACD histogram shows a modest bullish divergence (histogram +0.09) despite both MACD lines remaining negative. Fundamentally, the company is under pressure – revenue has contracted 7.7% YoY, operating margin is –13.7%, and the trailing EPS is –$0.42, resulting in a PE ratio of zero. The DCF‑derived fair value of $0.35 is dramatically lower than the current price, flagging a severe overvaluation. High volatility (30.9% 30‑day) and a decreasing volume trend further amplify uncertainty, while a beta of –0.06 implies near‑zero market correlation. The balance sheet is strained, with $28.1 M of debt versus $0.43 M of cash and a debt‑to‑equity ratio of 54, and ROE is negative at –1.6%.
Given these dynamics, the stock appears overvalued with limited upside unless a material operational turnaround or asset disposition occurs. Investors should weigh the heavy debt load, negative cash‑flow conversion, and lack of dividend against the modest technical support near $39 and the extreme “greed” market sentiment (Fear & Greed Index 88.98). A cautious stance is warranted, focusing on risk mitigation rather than aggressive positioning.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Current price far exceeds DCF fair value
  • Decreasing volume and high short‑term volatility
  • Negative earnings and operating margins

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential stabilization around support near $39
  • Neutral technical trend with slight bullish MACD signal
  • Debt reduction efforts could improve balance‑sheet health

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained negative profitability and high debt load
  • DCF valuation indicates a massive discount to market price
  • Liquidity constraints and limited analyst coverage

Key Metrics & Analysis

Financial Health

Revenue Growth-7.70%
Profit Margin-3.90%
ROE-1.62%
ROA-0.87%
Debt/Equity54.19
P/B Ratio1.6
Op. Cash Flow$2.3M
Free Cash Flow$2.1M
Industry P/E33.2

Technical Analysis

TrendNeutral
RSI40.3
Support$39.00
Resistance$43.55
MA 20$40.90
MA 50$43.03
MA 200$39.63
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98

Valuation

Fair Value$0.35
GradeOvervalued
TypeValue

Risk Assessment

Beta-0.06
Volatility30.86%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.